Advertisement

Nalbuphine Injection

[23 March 2015]

Products Affected - Description

Nalbuphine injection, Hospira
20 mg/mL 1 mL ampules (NDC 00409-1465-01)

Reason for the Shortage

  • Endo discontinued Nubain in 2008.
  • Teva discontinued all nalbuphine injections in July, 2010.
  • Hospira has nalbuphine on shortage due to increased demand.

Available Products

Nalbuphine injection, Hospira
10 mg/mL 1 mL ampules (NDC 00409-1463-01)
10 mg/mL 10 mL vials (NDC 00409-1464-01)
20 mg/mL 10 mL vials (NDC 00409-1467-01)

Estimated Resupply Dates

Hospira has nalbuphine 20 mg/mL 1 mL ampules on back order and the company estimates a release date of early-April 2015.

Related Shortages

Updated

March 23, February 23, January 6, 2015; December 12, September 17, June 26, April 30, March 13, January 3, 2014; November 1, October 7 and 18, September 4, August 9, July 2, June 10, May 9 and 30, April 1, March 5, February 22, January 21, 2013; December 10 and 31, November 9 and 28, October 24, September 13, August 7, July 12, May 8 and March 12 and 29, January 9, 2012; December 7, October 20 and 31, September 27, August 2 and 23, July 20, June 29, May 11 and 26, April 7 and 18, March 24, February 3 and 22, January 28, 2011; December 22, November 3, 4, 8, and 22, October 12 and 21, September 2, 14, and 30, August 20, July 20, 2010, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement